Wake Up Wall Street (SPY) (QQQ): Oil the focus as inflation woes could continue
Premium|Take advantage of 50% OFF on your first month.
Start your subscription and get access to all our original articles.
You have reached your limit of 5 free articles for this month.
Get Premium without limits for only $9.99 for the first month
Access all our articles, insights, and analysts.
UNLOCK OFFERHere is what you need to know on Thursday, October 6:
Equity markets remain on the up and up after a massive two-day rally earlier this week. That was expected to retreat on Wednesday, and initial signs were not good with most indices being down 2% in the first half of the day. Concerns over oil prices and the effect on inflation naturally hit sentiment, but traders returned from lunch in a bullish mood and lifted stocks to close almost flat on the day. This morning it is more of the same with futures once again indicating a lower open while yields tick higher. It is likely to be a low-volume day ahead of the big employment report on Friday. That will then set the pivot brigade up as hopes are high for a slowdown.
The dollar is higher this morning as risk assets retreat. The dollar index is at 111.51. Oil is calm but still elevated at $87.71, while Bitcoin is steady at $20,200. Gold trades at $1,718, little changed.
European markets are lower: Eurostoxx -0.65, FTSE -0.7%, and Dax -0.3%.
US futures are lower: S&P, Nasdaq, and dow making my job of typing easier by all being down 0.4%.
Wall Street top news (SPY) (QQQ)
White House to release more oil from strategic reserve after OPEC cuts.
WSJ reports White House may ease sanctions on Venezuela to tap more oil exports.
Apollo (APO), Twitter (TWTR): Apollo and Sixth Street are no longer in talks with Elon Musk over Twitter financing.
Blackrock (BLK): Louisana will pull $794 million out of its funds, according to the state Treasurer.
General Electric (GE) laying off workers at onshore wind unit.
Shell Oil (SHEL) says Q3 profit will be pressured by falling margins.
Conagra (CAG) up 2% on earnings.
Peloton (PTON) cutting more jobs, CEO Barry McCarthy tells WSJ it has another 6 months to sort itself out or may not be viable as a standalone firm.
Eli Lilly (LLY): Diabetes drug gets FDA fast track.
Upgrades and downgrades
Source: WSJ.com
Economic releases
Here is what you need to know on Thursday, October 6:
Equity markets remain on the up and up after a massive two-day rally earlier this week. That was expected to retreat on Wednesday, and initial signs were not good with most indices being down 2% in the first half of the day. Concerns over oil prices and the effect on inflation naturally hit sentiment, but traders returned from lunch in a bullish mood and lifted stocks to close almost flat on the day. This morning it is more of the same with futures once again indicating a lower open while yields tick higher. It is likely to be a low-volume day ahead of the big employment report on Friday. That will then set the pivot brigade up as hopes are high for a slowdown.
The dollar is higher this morning as risk assets retreat. The dollar index is at 111.51. Oil is calm but still elevated at $87.71, while Bitcoin is steady at $20,200. Gold trades at $1,718, little changed.
European markets are lower: Eurostoxx -0.65, FTSE -0.7%, and Dax -0.3%.
US futures are lower: S&P, Nasdaq, and dow making my job of typing easier by all being down 0.4%.
Wall Street top news (SPY) (QQQ)
White House to release more oil from strategic reserve after OPEC cuts.
WSJ reports White House may ease sanctions on Venezuela to tap more oil exports.
Apollo (APO), Twitter (TWTR): Apollo and Sixth Street are no longer in talks with Elon Musk over Twitter financing.
Blackrock (BLK): Louisana will pull $794 million out of its funds, according to the state Treasurer.
General Electric (GE) laying off workers at onshore wind unit.
Shell Oil (SHEL) says Q3 profit will be pressured by falling margins.
Conagra (CAG) up 2% on earnings.
Peloton (PTON) cutting more jobs, CEO Barry McCarthy tells WSJ it has another 6 months to sort itself out or may not be viable as a standalone firm.
Eli Lilly (LLY): Diabetes drug gets FDA fast track.
Upgrades and downgrades
Source: WSJ.com
Economic releases
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.